ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

JAGX 12.97

Jaguar Health Inc. (JAGX)

NASDAQ: JAGX · Real-Time Price · USD

12.97

1.10 (9.27%)

At close: May 02, 2025, 3:59 PM

12.68

-2.27%

After-hours: May 02, 2025, 05:40 PM EDT

Insider Trading

Transcripts

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

JAGX News

2 days ago - Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease Progression in Intestinal Failure Patients - accessnewswire.com
3 days ago - REMINDER: Jaguar Health Hosting April 30 Investor Webcast to Present Initial Results from Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) - accessnewswire.com
15 days ago - Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress - accessnewswire.com
17 days ago - Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting - accessnewswire.com
24 days ago - Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product - accessnewswire.com
28 days ago - Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - accessnewswire.com
31 days ago - Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules - accessnewswire.com
32 days ago - Jaguar Health, Inc. (JAGX) Q4 2024 Earnings Call Transcript - seekingalpha.com
32 days ago - Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 - accessnewswire.com
35 days ago - 83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - accessnewswire.com

Create Price Alert on JAGX

Symbol JAGX, Regular trading hours

Condition

Crossing

Value

Quick Summary:

Your price alert will notify you when the stock price is above 12.97.

Cancel

✕

Add to Watchlist

Sections

Stocks
ETFs
Blog
Learning Center

Services

Pricing
Discord Bot
Free Newsletter
FAQ

Website

Login
Sitemap
Advertise
Data Disclaimer
Referral Program

Company

About Us
Contact Us
Terms of Use
Privacy Policy
Imprint

Made in EU 🇪🇺 Stocknear is 100% Open Source⚡